Acute effects of treatment for prodromal symptoms for people putatively in a late initial prodromal state of psychosis

Diagnostic and Statistical Manual of Mental Disorders

Williams, J. B. W., & First, M. B. (2013) · Oxford University Press eBooks · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,841 · see citing works

Statistical Power Analysis for the Behavioral Sciences

Muller, K. E., & Cohen, J. (1989) · Technometrics · doi:10.2307/1270020 · Cited by 99,588 · see citing works

Statistical power analysis for the behavioral sciences

Cohen, J. (1990) · Computers Environment and Urban Systems · doi:10.1016/0198-9715(90)90050-4 · Cited by 65,406 · see citing works

The Positive and Negative Syndrome Scale (PANSS) for schizophrenia.

Kay, S. R., Fiszbein, A., & Opler, L. A. (1987) · Schizophrenia Bulletin · doi:10.1093/schbul/13.2.261 · Cited by 21,378 · see citing works

A new depression scale designed to be sensitive to change

Montgomery, S. A., & Åsberg, M. (1979) · British Journal of Psychiatry · doi:10.1192/bjp.134.4.382 · Cited by 13,962 · see citing works

The UKU side effect rating scale: A new comprehensive rating scale for psychotropic drugs and a cross‐sectional study of side effects in neuroleptic‐treated patients

Lingjærde, O., Ahlfors, U. G., Bech, P., Dencker, S. J., & Elgen, K. (1987) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1987.tb10566.x · Cited by 1,705 · see citing works

Revising axis V for DSM-IV: a review of measures of social functioning

Goldman, H. H., Skodol, A. E., & Lave, T. R. (1992) · American Journal of Psychiatry · doi:10.1176/ajp.149.9.1148 · Cited by 1,408 · see citing works

The NIMH-MATRICS Consensus Statement on Negative Symptoms

Kirkpatrick, B., Fenton, W. S., Carpenter, W. T., & Marder, S. R. (2006) · Schizophrenia Bulletin · doi:10.1093/schbul/sbj053 · Cited by 1,311 · see citing works

Randomized Controlled Trial of Interventions Designed to Reduce the Risk of Progression to First-Episode Psychosis in a Clinical Sample With Subthreshold Symptoms

McGorry, P. D., Yung, A. R., Phillips, L. J., Yuen, H. P., Francey, S., Cosgrave, E. M., Germano, D., Bravin, J., McDonald, T., Blair, A., et al. (2002) · Archives of General Psychiatry · doi:10.1001/archpsyc.59.10.921 · Cited by 1,056 · see citing works

Diagnosing schizophrenia in the initial prodromal phase

Klosterkötter, J., Hellmich, M., Steinmeyer, E. M., & Schultze-Lutter, F. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.2.158 · Cited by 1,049 · see citing works

Antipsychotic-Induced Hyperprolactinaemia: Mechanisms, Clinical Features and Management

Haddad, P. M., & Wieck, A. (2004) · Drugs · doi:10.2165/00003495-200464200-00003 · Cited by 634 · see citing works

IRAOS: an instrument for the assessment of onset and early course of schizophrenia

Häfner, H., Riecher‐Rössler, A., Hambrecht, M., Maurer, K., Meissner, S., Schmidtke, A., Fätkenheuer, B., Löffler, W., & der Heiden, W. A. (1992) · Schizophrenia Research · doi:10.1016/0920-9964(92)90004-o · Cited by 562 · see citing works

Amisulpride, an Unusual “Atypical” Antipsychotic: A Meta-Analysis of Randomized Controlled Trials

Leucht, S., Pitschel‐Walz, G., Engel, R. R., & Kissling, W. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.2.180 · Cited by 470 · see citing works

Manual for the Extrapyramidal Symptom Rating Scale (ESRS)

Chouinard, G., & Margolese, H. C. (2005) · Schizophrenia Research · doi:10.1016/j.schres.2005.02.013 · Cited by 418 · see citing works

Testing the Ultra High Risk (prodromal) criteria for the prediction of psychosis in a clinical sample of young people.

Yung, A., Stanford, C., Cosgrave, E., Killackey, E., Phillips, L., Nelson, B., & McGorry, P. (2006) · Schizophrenia Research · doi:10.1016/j.schres.2006.03.014 · Cited by 299 · see citing works

The ABC schizophrenia study: a preliminary overview of the results

Häfner, H., Maurer, K., Löffler, W., der Heiden, W. A., Munk‐Jørgensen, P., Hambrecht, M., & Riecher‐Rössler, A. (1998) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s001270050069 · Cited by 253 · see citing works

Randomized trial of olanzapine versus placebo in the symptomatic acute treatment of the schizophrenic prodrome

Woods, S. W., Breier, A. F., Zipursky, R. B., Perkins, D. O., Addington, J., Miller, T. J., Hawkins, K. A., Márquez, E. M. A., Lindborg, S. R., Tohen, M. F., et al. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00321-4 · Cited by 220 · see citing works

Early detection and secondary prevention of psychosis: facts and visions*

H�fner, H., Maurer, K., Ruhrmann, S., Bechdolf, A., Klosterk�tter, J., Wagner, M., Maier, W., Ronald Bottlender, A., M�ller, H.-J., Gäebel, W., et al. (2004) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-004-0508-z · Cited by 214 · see citing works

Identification of young people at risk of psychosis: validation of Personal Assessment and Crisis Evaluation Clinic intake criteria.

Phillips, L., Yung, A., & McGorry, P. (2000) · Australian and New Zealand journal of psychiatry (Print) · doi:10.1080/000486700239 · Cited by 207 · see citing works

Neurocognitive Functioning in Subjects at Risk for a First Episode of Psychosis Compared with First- and Multiple-episode Schizophrenia

Pukrop, R., Schultze‐Lutter, F., Ruhrmann, S., Brockhaus‐Dumke, A., Tendolkar, I., Bechdolf, A., Matuschek, E., & Klosterkötter, J. (2006) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/13803390500434425 · Cited by 146 · see citing works

Amisulpride versus fluoxetine in patients with dysthymia or major depression in partial remission A double-blind, comparative study

Smeraldi, E. (1998) · Journal of Affective Disorders · doi:10.1016/s0165-0327(97)00139-0 · Cited by 104 · see citing works

Subjective quality of life in subjects at risk for a first episode of psychosis: A comparison with first episode schizophrenia patients and healthy controls

Bechdolf, A., Pukrop, R., Köhn, D., Tschinkel, S., Veith, V., Schultze‐Lutter, F., Ruhrmann, S., Geyer, C., Pohlmann, B., & Klosterkötter, J. (2005) · Schizophrenia Research · doi:10.1016/j.schres.2005.06.008 · Cited by 92 · see citing works

Food and Drug Administration Perspective on Negative Symptoms in Schizophrenia as a Target for a Drug Treatment Claim

LAUGHREN, T. P., & Levin, R. L. (2005) · Schizophrenia Bulletin · doi:10.1093/schbul/sbi039 · Cited by 79 · see citing works

Pharmacological intervention in the initial prodromal phase of psychosis

Ruhrmann, S., Schultze‐Lutter, F., Maier, W., & Klosterkötter, J. (2004) · European Psychiatry · doi:10.1016/j.eurpsy.2004.11.001 · Cited by 75 · see citing works

Negative symptoms in schizophrenia: considerations for clinical trials

Möller, H. ‐., van Praag, H. M., Aufdembrinke, B., Bailey, P., Barnes, T. R. E., Beck, J., Bentsen, H., Eich, F. X., Farrow, L. R., Fleischhacker, W. W., et al. (1994) · Psychopharmacology · doi:10.1007/bf02244775 · Cited by 71 · see citing works

Identification of young people at risk of psychosis: validation of Personal Assessment and Crisis Evaluation Clinic intake criteria

Phillips, L., Yung, A. R., & McGorry, P. D. (2000) · Australian & New Zealand Journal of Psychiatry · doi:10.1046/j.1440-1614.2000.00798.x · Cited by 67 · see citing works

Prolactinemia is uncoupled from central D2/D3 dopamine receptor occupancy in amisulpride treated patients

Bressan, R. A., Erlandsson, K., Spencer, E. P., Ell, P. J., & Pilowsky, L. S. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1826-6 · Cited by 44 · see citing works

Amisulpride is an ?atypical? antipsychotic associated with low weight gain

Leucht, S., Wagenpfeil, S., Hamann, J., & Kissling, W. (2004) · Psychopharmacology · doi:10.1007/s00213-003-1721-6 · Cited by 41 · see citing works

Früherkennung des Psychoserisikos mit dem Early Recognition Inventory (ERIraos)

Hörrmann, F., Trendler, G., Schmidt, M. H., Häfner, H., Maier, W. A., III, Wagner, M., Gäebel, W., Wölwer, W., Klosterkötter, J., Schultze‐Lutter, F., et al. (2006) · Nervenheilkunde · doi:10.1055/s-0038-1626434 · Cited by 40 · see citing works

Early detection and intervention in psychosis: an ethical paradigm shift

McGlashan, T. H. (2005) · The British Journal of Psychiatry · doi:10.1192/bjp.187.48.s113 · Cited by 39 · see citing works

Hyperprolactinemia after low dose of amisulpride.

Kopeček, M., Bareš, M., Švarc, J., Dockery, C. A., & Horáček, J. (2004) · PubMed · Cited by 38 · see citing works

Long-Term Effects of the Substituted Benzamide Derivative Amisulpride on Baseline and Stimulated Prolactin Levels

Schlösser, R. G. M., Gründer, G., Anghelescu, I. G., Hillert, A., Ewald-Gründer, S., Hiemke, C., & Benkert, O. (2002) · Neuropsychobiology · doi:10.1159/000063574 · Cited by 35 · see citing works

Focus on Amisulpride

Green, B. (2002) · Current Medical Research and Opinion · doi:10.1185/030079902125000363 · Cited by 18 · see citing works

Prediction of Psychosis in Adolescents and Young Adults at High Risk: Results From the Prospective European Prediction of Psychosis Study

Ruhrmann, S., Schultze-Lutter, F., Salokangas, R. K. R., Heinimaa, M., Linszen, D., Dingemans, P., Birchwood, M., Patterson, P., Juckel, G., Heinz, A., et al. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.206 · Cited by 632 · see citing works

Evidence-based guidelines for the pharmacological treatment of schizophrenia: Updated recommendations from the British Association for Psychopharmacology

Barnes, T. R. E., Drake, R., Paton, C., Cooper, S. J., Deakin, J. F. W., Ferrier, I. N., Gregory, C. J., Haddad, P. M., Howes, O. D., Jones, I. R., et al. (2019) · Journal of Psychopharmacology · doi:10.1177/0269881119889296 · Cited by 607 · see citing works

The Role of Genes, Stress, and Dopamine in the Development of Schizophrenia

Howes, O. D., McCutcheon, R. A., Owen, M. J., & Murray, R. M. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2016.07.014 · Cited by 604 · see citing works

EPA guidance on the early intervention in clinical high risk states of psychoses

Schmidt, S. J., Schultze-Lutter, F., Schimmelmann, B. G., Maric, N. P., Salokangas, R. K. R., Riecher-Rössler, A., van der Gaag, M., Meneghelli, A., Nordentoft, M., Marshall, M., et al. (2015) · European Psychiatry · doi:10.1016/j.eurpsy.2015.01.013 · Cited by 585 · see citing works

Early intervention for psychosis

Marshall, M., & Rathbone, J. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004718.pub3 · Cited by 531 · see citing works

Early interventions to prevent psychosis: systematic review and meta-analysis

Stafford, M. R., Jackson, H., Mayo-Wilson, E., Morrison, A. P., & Kendall, T. (2013) · BMJ · doi:10.1136/bmj.f185 · Cited by 456 · see citing works

Long-term Follow-up of a Group at Ultra High Risk (“Prodromal”) for Psychosis

Nelson, B., Yuen, H. P., Wood, S. J., Lin, A. P., Spiliotacopoulos, D., Bruxner, A., Broussard, C., Simmons, M. B., Foley, D. L., Brewer, W. J., et al. (2013) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2013.1270 · Cited by 434 · see citing works

EPA guidance on the early detection of clinical high risk states of psychoses

Schultze‐Lutter, F., Michel, C., Schmidt, S. J., SCHIMMELMANN, B. G., Marić, N. P., Salokangas, R. K. R., Riecher‐Rössler, A., van der Gaag, M., Nordentoft, M., Raballo, A., et al. (2015) · European Psychiatry · doi:10.1016/j.eurpsy.2015.01.010 · Cited by 405 · see citing works

Evidence-based guidelines for the pharmacological treatment of schizophrenia: recommendations from the British Association for Psychopharmacology

Barnes, T. R. E. (2011) · Journal of Psychopharmacology · doi:10.1177/0269881110391123 · Cited by 357 · see citing works

Lack of evidence to favor specific preventive interventions in psychosis: a network meta‐analysis

Davies, C., Cipriani, A., Ioannidis, J. P. A., Radua, J., Stahl, D., Provenzani, U., McGuire, P., & Fusar‐Poli, P. (2018) · World Psychiatry · doi:10.1002/wps.20526 · Cited by 229 · see citing works

Abnormal Frontostriatal Interactions in People With Prodromal Signs of Psychosis: A Multimodal Imaging Study

Fusar-Poli, P., Howes, O. D., Allen, P., Broome, M., Valli, I., Asselin, M.-C., Grasby, P. M., & McGuire, P. K. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.77 · Cited by 234 · see citing works

Beyond the critical period: longitudinal study of 8-year outcome in first-episode non-affective psychosis

Crumlish, N., Whitty, P., Clarke, M., Browne, S., Kamali, M., Gervin, M., McTigue, O., Kinsella, A., Waddington, J. L., Larkin, C., et al. (2008) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.107.048942 · Cited by 213 · see citing works

Early signs, diagnosis and therapeutics of the prodromal phase of schizophrenia and related psychotic disorders

Larson, M. K., Walker, E. F., & Compton, M. T. (2010) · Expert Review of Neurotherapeutics · doi:10.1586/ern.10.93 · Cited by 203 · see citing works

Research in people with psychosis risk syndrome: a review of the current evidence and future directions

Correll, C. U., Hauser, M., Auther, A. M., & Cornblatt, B. A. (2010) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.2010.02235.x · Cited by 196 · see citing works

Randomized-controlled trials in people at ultra high risk of psychosis: A review of treatment effectiveness

Preti, A., & Cella, M. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2010.07.026 · Cited by 167 · see citing works

Probably at-risk, but certainly ill — Advocating the introduction of a psychosis spectrum disorder in DSM-V

Ruhrmann, S., Schultze-Lutter, F., & Klosterkötter, J. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2010.03.015 · Cited by 147 · see citing works

The psychosis threshold in Ultra High Risk (prodromal) research: Is it valid?

Yung, A. R., Nelson, B., Thompson, A. D., & Wood, S. J. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2010.03.014 · Cited by 143 · see citing works

The case for including Attenuated Psychotic Symptoms Syndrome in DSM-5 as a psychosis risk syndrome

Woods, S. W., Walsh, B. C., Saksa, J. R., & McGlashan, T. H. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2010.08.012 · Cited by 130 · see citing works

What drives poor functioning in the at-risk mental state? A systematic review

Cotter, J., Drake, R., Bucci, S., Firth, J., Edge, D., & Yung, A. R. (2014) · Schizophrenia Research · doi:10.1016/j.schres.2014.09.012 · Cited by 111 · see citing works

Preventive Treatments for Psychosis: Umbrella Review (Just the Evidence)

Fusar-Poli, P., Davies, C., Solmi, M., Brondino, N., De Micheli, A., Kotlicka-Antczak, M., Shin, J. I., & Radua, J. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00764 · Cited by 108 · see citing works

Interventions for prodromal stage of psychosis

Kuharić, D. B., Kekin, I., Hew, J., Kuzman, M. R., & Puljak, L. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012236.pub2 · Cited by 102 · see citing works

Applications of blood-based protein biomarker strategies in the study of psychiatric disorders

Chan, M. K., Gottschalk, M. G., Haenisch, F., Tomasik, J., Ruland, T., Rahmoune, H., Guest, P. C., & Bahn, S. (2014) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2014.08.002 · Cited by 94 · see citing works

Early intervention in patients at ultra high risk of psychosis: benefits and risks

de Koning, M. B., Bloemen, O., van Amelsvoort, T., Becker, H. E., Nieman, D. H., van der Gaag, M., & Linszen, D. H. (2009) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2009.01372.x · Cited by 90 · see citing works

Progress and Future Directions in Research on the Psychosis Prodrome

Woodberry, K. A., Shapiro, D. I., Bryant, C., & Seidman, L. J. (2016) · Harvard Review of Psychiatry · doi:10.1097/hrp.0000000000000109 · Cited by 87 · see citing works

Should a “Risk Syndrome for Psychosis” be included in the DSMV?

Yung, A. R., Nelson, B., Thompson, A. D., & Wood, S. J. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2010.03.017 · Cited by 85 · see citing works

Negative Symptom Interventions in Youth at Risk of Psychosis: A Systematic Review and Network Meta-analysis

Devoe, D. J. A., Peterson, A. M., & Addington, J. (2017) · Schizophrenia Bulletin · doi:10.1093/schbul/sbx139 · Cited by 79 · see citing works

Ultra high risk (UHR) for psychosis criteria: Are there different levels of risk for transition to psychosis?

Nelson, B., Yuen, K., & Yung, A. R. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2010.10.017 · Cited by 80 · see citing works

Attenuated psychotic symptom interventions in youth at risk of psychosis: A systematic review and meta‐analysis

Devoe, D. J. A., Farris, M. S., Townes, P., & Addington, J. (2018) · Early Intervention in Psychiatry · doi:10.1111/eip.12677 · Cited by 80 · see citing works

Antidepressant, antipsychotic and psychological interventions in subjects at high clinical risk for psychosis: OASIS 6-year naturalistic study

Fusar-Poli, P., Frascarelli, M., Valmaggia, L., Byrne, M., Stahl, D., Rocchetti, M., Codjoe, L., Weinberg, L., Tognin, S., Xenaki, L., et al. (2015) · Psychological Medicine · doi:10.1017/s003329171400244x · Cited by 73 · see citing works

The staging model in schizophrenia, and its clinical implications.

Agius, M. A., Goh, C., Ulhaq, S., & McGorry, P. D. (2010) · PubMed · Cited by 68 · see citing works

Reduced subjective quality of life in persons at risk for psychosis

Ruhrmann, S., Paruch, J., Bechdolf, A., Pukrop, R., Wagner, M., Berning, J., Schultze-Lutter, F., Janssen, B., Gäebel, W., Möller, H. ‐., et al. (2008) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2008.01152.x · Cited by 68 · see citing works

Rationale and Baseline Characteristics of PREVENT: A Second-Generation Intervention Trial in Subjects At-Risk (Prodromal) of Developing First-Episode Psychosis Evaluating Cognitive Behavior Therapy, Aripiprazole, and Placebo for the Prevention of Psychosis

Bechdolf, A., Müller, H., Stützer, H., Wagner, M., Maier, W., Lautenschlager, M., Heinz, A., de Millas, W., Janssen, B., Gäebel, W., et al. (2011) · Schizophrenia Bulletin · doi:10.1093/schbul/sbr083 · Cited by 66 · see citing works

Prodromal psychosis screening in adolescent psychiatry clinics

Loewy, R. L., Therman, S., Manninen, M., HUTTUNEN, M. O., & Cannon, T. D. (2011) · Early Intervention in Psychiatry · doi:10.1111/j.1751-7893.2011.00286.x · Cited by 66 · see citing works

The relation of antipsychotic and antidepressant medication with baseline symptoms and symptom progression: A naturalistic study of the North American Prodrome Longitudinal Sample

Walker, E. F., Cornblatt, B. A., Addington, J., Cadenhead, K. S., Cannon, T. D., McGlashan, T. H., Perkins, D. O., Seidman, L. J., Tsuang, M. T., Woods, S. W., et al. (2009) · Schizophrenia Research · doi:10.1016/j.schres.2009.07.023 · Cited by 65 · see citing works

Glycine treatment of the risk syndrome for psychosis: Report of two pilot studies

Woods, S. W., Walsh, B. C., Hawkins, K. A., Miller, T. J., Saksa, J. R., D’Souza, D. C., Pearlson, G. D., Javitt, D. C., McGlashan, T. H., & Krystal, J. H. (2012) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2012.09.008 · Cited by 61 · see citing works

Progression from being at-risk to psychosis: next steps

Addington, J., Farris, M., Devoe, D., & Metzak, P. D. (2020) · npj Schizophrenia · doi:10.1038/s41537-020-00117-0 · Cited by 50 · see citing works

Kraepelin and psychotic prodromal conditions

Klosterkötter, J., Schultze‐Lutter, F., & Ruhrmann, S. (2008) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-008-2010-5 · Cited by 55 · see citing works

Three-year course of clinical symptomatology in young people at ultra high risk for transition to psychosis

Velthorst, E., Nieman, D. H., Klaassen, R. M. C., Becker, H. E., Dingemans, P. M. A. J., Linszen, D. H., & de Haan, L. (2010) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2010.01593.x · Cited by 48 · see citing works

Psychotherapy for adolescents and young adults at high risk for psychosis: a systematic review

Okuzawa, N., Kline, E. R., Fuertes, J., Negi, S., Reeves, G. M., Himelhoch, S. S., & Schiffman, J. E. (2014) · Early Intervention in Psychiatry · doi:10.1111/eip.12129 · Cited by 44 · see citing works

Intervention strategies for ultra-high risk for psychosis: Progress in delaying the onset and reducing the impact of first-episode psychosis

McGorry, P. D., Mei, C., Hartmann, J., Yung, A. R., & Nelson, B. (2021) · Schizophrenia Research · doi:10.1016/j.schres.2020.12.026 · Cited by 45 · see citing works

Prediction and Prevention in the Clinical High-Risk for Psychosis Paradigm: A Review of the Current Status and Recommendations for Future Directions of Inquiry

Worthington, M., & Cannon, T. D. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.770774 · Cited by 43 · see citing works

Treatment of early-onset schizophrenia

Mattai, A. K., Hill, J. L., & Lenroot, R. (2010) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e32833b027e · Cited by 42 · see citing works

An update on: meta-analysis of medical and non-medicaltreatments of the prodromal phase of psychotic illness in at risk mental states.

Deas, G., Kelly, C. J., Hadjinicolaou, A. V., Holt, C., Agius, M. A., & Zaman, R. (2016) · PubMed · Cited by 44 · see citing works

A promoter variant of SHANK1 affects auditory working memory in schizophrenia patients and in subjects clinically at risk for psychosis

Lennertz, L., Wagner, M., Wölwer, W., Schuhmacher, A., Frommann, I., Berning, J., Schulze‐Rauschenbach, S., Landsberg, M. W., Steinbrecher, A., Alexander, M., et al. (2011) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-011-0233-3 · Cited by 42 · see citing works

Psychotropic medication use in youth at high risk for psychosis: Comparison of baseline data from two research cohorts 1998–2005 and 2008–2011

Woods, S. W., Addington, J., Bearden, C. E., Cadenhead, K. S., Cannon, T. D., Cornblatt, B. A., Mathalon, D. H., Perkins, D. O., Seidman, L. J., Tsuang, M. T., et al. (2013) · Schizophrenia Research · doi:10.1016/j.schres.2013.05.019 · Cited by 40 · see citing works

Biofeedback to treat anxiety in young people at clinical high risk for developing psychosis

McAusland, L., & Addington, J. (2018) · Early Intervention in Psychiatry · doi:10.1111/eip.12368 · Cited by 37 · see citing works

Consensus on potential biomarkers developed for use in clinical tests for schizophrenia

Lin, P., Sun, J., Lou, X., Li, D., Shi, Y., Li, Z., Ma, P., Li, P., Chen, S., Jin, W., et al. (2022) · General Psychiatry · doi:10.1136/gpsych-2021-100685 · Cited by 38 · see citing works

Glutamate and Psychosis Risk

Egerton, A., Fusar-Poli, P., & M. Stone, J. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212799316244 · Cited by 36 · see citing works

Primary prevention of psychosis through interventions in the symptomatic prodromal phase, a pragmatic Norwegian Ultra High Risk study

Joa, I., Gisselgård, J., Brønnick, K., McGlashan, T. H., & Johannessen, J. O. (2015) · BMC Psychiatry · doi:10.1186/s12888-015-0470-5 · Cited by 34 · see citing works

Multidisciplinary Treatment for Individuals at Clinical High Risk of Developing Psychosis

Addington, J., Devoe, D. J. A., & Santesteban‐Echarri, O. (2019) · Current Treatment Options in Psychiatry · doi:10.1007/s40501-019-0164-6 · Cited by 33 · see citing works

Attrition rates in trials for adolescents and young adults at clinical high‐risk for psychosis: A systematic review and meta‐analysis

Farris, M. S., Devoe, D. J. A., & Addington, J. (2019) · Early Intervention in Psychiatry · doi:10.1111/eip.12864 · Cited by 33 · see citing works

Neurocognitive function as a possible marker for remission from clinical high risk for psychosis

Lee, T. Y., Shin, Y. S., Shin, N. Y., Kim, S. N., Jang, J. H., Kang, D., & Kwon, J. S. (2014) · Schizophrenia Research · doi:10.1016/j.schres.2014.01.018 · Cited by 32 · see citing works

Negative symptoms mediate the relationship between neurocognition and function in individuals at ultrahigh risk for psychosis

Glenthøj, L. B., Jepsen, J. R. M., Hjorthøj, C. R., Bak, N. K., Kristensen, T. D., Wenneberg, C., Krakauer, K., Nordentoft, M., & Fagerlund, B. (2016) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12682 · Cited by 32 · see citing works

Treatment Implications of the Schizophrenia Prodrome

Kaur, T., & Cadenhead, K. S. (2010) · Current topics in behavioral neurosciences · doi:10.1007/7854_2010_56 · Cited by 32 · see citing works

Treating young individuals at clinical high risk for psychosis

Marshall, C., Addington, J., Epstein, I., Liu, L., Deighton, S., & Zipursky, R. B. (2011) · Early Intervention in Psychiatry · doi:10.1111/j.1751-7893.2011.00299.x · Cited by 30 · see citing works

Psychological interventions for people with psychotic experiences: A systematic review and meta-analysis of controlled and uncontrolled effectiveness and economic studies

Soneson, E., Russo, D. A., Štochl, J., Heslin, M., Galante, J., Knight, C., Grey, N., Hodgekins, J., French, P., Fowler, D. G., et al. (2020) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867420913118 · Cited by 29 · see citing works

Effects of Aripiprazole on Insight and Subjective Experience in Individuals With an At-Risk Mental State

Kobayashi, H., Morita, K., Takeshi, K., Koshikawa, H., Yamazawa, R., Kashima, H., & Mizuno, M. (2009) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3181b2fe22 · Cited by 29 · see citing works

Intervention in the at-risk state to prevent transition to psychosis

Ruhrmann, S., Schultze‐Lutter, F., & Klosterkötter, J. (2009) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e328324b687 · Cited by 29 · see citing works

Pharmacotherapy in Children and Adolescents at Clinical-High Risk for Psychosis and Bipolar Disorder

Lambert, M., Niehaus, V., & Correll, C. U. (2016) · Pharmacopsychiatry · doi:10.1055/s-0042-116668 · Cited by 28 · see citing works

Antipsychotic Interventions in Prodromal Psychosis

Liu, C., & Demjaha, A. (2013) · CNS Drugs · doi:10.1007/s40263-013-0046-1 · Cited by 28 · see citing works

Practitioner Review: Schizophrenia spectrum disorders and the at‐risk mental state for psychosis in children and adolescents – evidence‐based management approaches

Tiffin, P. A., & Welsh, P. (2013) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.12136 · Cited by 27 · see citing works

Update on the management of symptoms in schizophrenia: focus on amisulpride

Mortimer, A. M. (2009) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s3949 · Cited by 27 · see citing works

Pharmacotherapy and clinical characteristics of ultra‐high‐risk for psychosis according to conversion status: a naturalistic observational study

Kim, E., Jang, J. H., Park, H., Shim, G., Hwang, J. Y., Kim, S. N., & Kwon, J. S. (2011) · Early Intervention in Psychiatry · doi:10.1111/j.1751-7893.2011.00295.x · Cited by 21 · see citing works

At-risk mental state for psychosis: identification and current treatment approaches

Thompson, A. D., Marwaha, S., & Broome, M. R. (2016) · BJPsych Advances · doi:10.1192/apt.bp.115.015487 · Cited by 21 · see citing works

Intervention in at-risk states for developing psychosis

Ruhrmann, S., Schultze‐Lutter, F., Bechdolf, A., & Klosterkötter, J. (2010) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-010-0139-5 · Cited by 20 · see citing works

Aripiprazole for Drug-Naive or Antipsychotic-Short-Exposure Subjects With Ultra-High Risk State and First-Episode Psychosis

Liu, C., Chien, Y., Hsieh, M. H., Hwang, T., Hwu, H., & Liu, C. (2012) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31827cb017 · Cited by 20 · see citing works

The Common Elements of treatment engagement for clinically high‐risk youth and youth with first‐episode psychosis

Becker, K. D., Buckingham, S. L., Rith‐Najarian, L., & Kline, E. R. (2015) · Early Intervention in Psychiatry · doi:10.1111/eip.12283 · Cited by 19 · see citing works

Identification and treatment of the prodromal phase of psychotic disorders: perspectives from the PACE Clinic

Yung, A. R. (2007) · Early Intervention in Psychiatry · doi:10.1111/j.1751-7893.2007.00033.x · Cited by 19 · see citing works

Young people at ultra high risk for psychosis: research from the PACE clinic

Yung, A. R., & Nelson, B. (2011) · Brazilian Journal of Psychiatry · doi:10.1590/s1516-44462011000600003 · Cited by 19 · see citing works

Expanding the Boundaries of Early Intervention for Psychosis: Intervening During the Prodrome

Auther, A. M., Gillett, D. A., & Cornblatt, B. A. (2008) · Psychiatric Annals · doi:10.3928/00485713-20080801-02 · Cited by 17 · see citing works

Antipsychotic treatment of UHR (‘prodromal’) individuals

Yung, A. R. (2010) · Early Intervention in Psychiatry · doi:10.1111/j.1751-7893.2010.00191.x · Cited by 16 · see citing works

Prävention psychotischer Störungen

Klosterkötter, J. (2013) · Der Nervenarzt · doi:10.1007/s00115-013-3831-7 · Cited by 15 · see citing works

Prospective outcome of early intervention for individuals at ultra‐high‐risk for psychosis

Shim, G., Kang, D., Choi, J., Jung, M. H., Kwon, J. S., Jang, G.-E., & Kwon, J. S. (2008) · Early Intervention in Psychiatry · doi:10.1111/j.1751-7893.2008.00089.x · Cited by 15 · see citing works

Effects of interactions between variation in dopaminergic genes, traumatic life events, and anomalous self-experiences on psychosis proneness: Results from a cross-sectional study in a nonclinical sample

Frydecka, D., Kotowicz, K., Gawęda, Ł., Prochwicz, K., Kłosowska, J., Rymaszewska, J., Samochowiec, A., Samochowiec, J., Podwalski, P., Pawlak, E., et al. (2020) · European Psychiatry · doi:10.1192/j.eurpsy.2020.103 · Cited by 14 · see citing works

Early Detection and Prevention of Schizophrenic Psychosis—A Review

Westhoff, M. S., Ladwig, J., Heck, J., Schülke, R., Groh, A., Deest, M., Bleich, S., Frieling, H., & Jahn, K. (2021) · Brain Sciences · doi:10.3390/brainsci12010011 · Cited by 14 · see citing works

Managing the Prodrome of Schizophrenia

Fleischhacker, W. W., & Simma, A. M. (2012) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-25761-2_5 · Cited by 14 · see citing works

Prediction and prevention of the first psychotic episode: new directions and opportunities

Marchese, G., Piras, S., Casu, G., Casu, M. A., Orrù, A., Ruiu, S., Pilleri, A., & Manca, G. (2014) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s55770 · Cited by 13 · see citing works

Efficacy of second-generation antipsychotics in patients at ultra-high risk and those with first- episode or multi-episode schizophrenia

Washida, K., Aoki, Habara, Sato, Oka, Takeda, Yosimura, & Tanaka (2013) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s45697 · Cited by 12 · see citing works

‘I’m not insane, my mother had me tested’: the risk and benefits of being labelled ‘at-risk’ for psychosis

Welsh, P., & Brown, S. R. (2013) · Health Risk & Society · doi:10.1080/13698575.2013.848846 · Cited by 12 · see citing works

Rapid response to antipsychotic treatment on psychotic prodrome: Implications from a case series

Liu, C., Sheu, Y.-H., Wu, S., Lai, M., & Hwu, H. (2010) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2010.02070.x · Cited by 11 · see citing works

Meta-analysis of medical and non-medical treatments of the prodromal phase of psychotic illness in at-risk mental states.

Kelly, C. J., Hadjinicolaou, A. V., Holt, C., Agius, M. A., & Zaman, R. (2010) · PubMed · Cited by 11 · see citing works

Early psychotic experiences: Interventions, problems and perspectives.

Dimitrakopoulos, S., Kollias, C. T., Stefanis, N. C., & Kontaxakis, V. P. (2015) · PubMed · Cited by 10 · see citing works

Predicting clinical response in people at ultra-high risk of psychosis: a systematic and quantitative review

Mechelli, A., Prata, D. P., Kefford, C., & Kapur, S. (2015) · Drug Discovery Today · doi:10.1016/j.drudis.2015.03.003 · Cited by 9 · see citing works

Adolescents and young adults at ultrahigh risk of psychosis: detection, prediction and treatment. A review of current knowledge.

Mees, L., Zdanowicz, N., Reynaert, C., & Jacques, D. (2011) · PubMed · Cited by 8 · see citing works

Attitudes of patients and clinicians in relation to the at‐risk state for psychosis

Welsh, P., & Tiffin, P. A. (2013) · Early Intervention in Psychiatry · doi:10.1111/eip.12062 · Cited by 7 · see citing works

Is clinical intervention in the ultra high risk phase effective?

McGuire, P. K., Selvaraj, S., & Howes, O. D. (2011) · Brazilian Journal of Psychiatry · doi:10.1590/s1516-44462011000600004 · Cited by 7 · see citing works

Does early diagnosis and treatment of schizophrenia lead to improved long-term outcomes?

Agius, M. A., Butler, S., & Holt, C. (2011) · Neuropsychiatry · doi:10.2217/npy.11.71 · Cited by 7 · see citing works

Neurophysiological differences between patients clinically at high risk for schizophrenia and neurotypical controls – first steps in development of a biomarker

Duffy, F. H., D’Angelo, E. J., Rotenberg, A., & Gonzalez–Heydrich, J. (2015) · BMC Medicine · doi:10.1186/s12916-015-0516-z · Cited by 6 · see citing works

Research in young people at ultra-high risk for psychosis: a review of the current evidence

O’Connor, K. (2013) · Irish Journal of Psychological Medicine · doi:10.1017/ipm.2012.9 · Cited by 6 · see citing works

Pharmacological Treatment of Schizophrenia:

Fleischhacker, W. W., & Miyamoto, S. (2016) · Clinical Neuropsychopharmacology and Therapeutics · doi:10.5234/cnpt.7.1 · Cited by 6 · see citing works

Early Intervention for Better Mental Health Services

Rosen, A., Byrne, P., Goldstone, S. D., & McGorry, P. D. (2015) · Wiley eBooks · doi:10.1002/9781118753378.ch99 · Cited by 6 · see citing works

Early detection of schizophrenia

Klosterkötter, J. (2011) · Neurology Psychiatry and Brain Research · doi:10.1016/j.npbr.2011.02.001 · Cited by 5 · see citing works

Providing care to young people with emerging risk of psychosis: balancing potential risks and benefits

McGorry, P. D., Nelson, B., & Goldstone, S. D. (2012) · Clinical Practice · doi:10.2217/cpr.12.69 · Cited by 5 · see citing works

Assessment and treatment of the risk of psychosis in adolescents--a review.

Zdanowicz, N., Mees, L., Jacques, D., Tordeurs, D., & Reynaert, C. (2014) · PubMed · Cited by 5 · see citing works

Psychosis Risk Syndrome: What Now?

Sentissi, O., ANDREOU, M. A., Moeglin, C., Curtis, L., & BROSCH, M. S. (2017) · Journal of Psychiatric Practice · doi:10.1097/pra.0000000000000272 · Cited by 5 · see citing works

At-risk mental state and prediction

Yung, A. R., Klosterkötter, J., Cornblatt, B. A., & Schultze‐Lutter, F. (2009) · Cambridge University Press eBooks · doi:10.1017/cbo9780511576287.007 · Cited by 5 · see citing works

The Prodrome of Schizophrenia

Addington, J., & Lewis, S. W. (2010) · doi:10.1002/9781444327298.ch6 · Cited by 5 · see citing works

Very Early Interventions in Psychotic Disorders

Bhangoo, R. K., & Carter, C. S. (2009) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2008.10.003 · Cited by 4 · see citing works

Early detection and treatment of patients symptomatically at-risk for psychosis

Schultze‐Lutter, F., Ruhrmann, S., & Schimmelmann, B. K. E. (2012) · Cited by 4 · see citing works

Sollen bei Prodromalstadien der Schizophrenie Antipsychotika zur Psychoseprävention eingesetzt werden? Pro

Lambert, M., & Correll, C. U. (2015) · Der Nervenarzt · doi:10.1007/s00115-015-4427-1 · Cited by 4 · see citing works

Aripiprazole in the treatment of the psychosis prodrome

Woods, S. W., Tully, E. M., Walsh, B. C., Hawkins, K. A., Callahan, J. L., Cohen, S. J., Mathalon, D. H., Miller, T. J., & McGlashan, T. H. (2007) · The British Journal of Psychiatry · doi:10.1192/bjp.191.51.s96 · Cited by 126 · see citing works

Rapid response to antipsychotic treatment on psychotic prodrome: Implications from a case series

Liu, C., Sheu, Y.-H., Wu, S., Lai, M., & Hwu, H. (2010) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2010.02070.x · Cited by 11 · see citing works

REVIEW The use of amisulpride in the treatment of acute psychosis

Hummer, M., & Tessier, C. (2013)

The use of amisulpride in the treatment of acute psychosis

Nuss, P., Hummer, M., & Tessier, C. (2007) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.2007.3.1.3 · Cited by 17 · see citing works

The relation of antipsychotic and antidepressant medication with baseline symptoms and symptom progression: A naturalistic study of the North American Prodrome Longitudinal Sample

Walker, E. F., Cornblatt, B. A., Addington, J., Cadenhead, K. S., Cannon, T. D., McGlashan, T. H., Perkins, D. O., Seidman, L. J., Tsuang, M. T., Woods, S. W., et al. (2009) · Schizophrenia Research · doi:10.1016/j.schres.2009.07.023 · Cited by 65 · see citing works